NCMM PhD digital course in Molecular Medicine 2020: MF9120BTS

NCMM's annual national PhD course in molecular medicine will feature a number of talks from leading researchers. Please note that the course will now take place entirely online. 

NCMM logo

MF9120BTS NCMM Molecular Medicine Research Course

PLEASE NOTE: All talks will now take place online via Zoom. 

A full programme and time plan is available as a pdf: 

Download a PDF of the course programme.

Topics and Programme

1.    Disease mechanisms and development (7 h)
a.    Targeting signaling pathways in cancer (1h, Sigrid Skånland)
b.    Inflammation (2h, Bente Halvorsen/Espen Melum)
c.    Metabolic diseases, diabetes (1h, Pål Njølstad)
d.    Epigenetics and chromatin structure (1h, Nikolina Sekulic)
e.    DNA repair mechanisms (1h, Hilde Nilsen)
f.    Disease mechanism and risk factors of venous thrombosis (1h, Lynn Butler)

2.    Animal models of disease (3.5 h)
a.    Stem cells and organoids (1h, Judith Staerk)
b.    Disease mechanisms and animal models of cardiovascular disease (1.5h, Andreas Romaine /Arne Olav Melleby)
c.    The use of zebrafish to model and understand mechanisms underlying neurological disorder (1h, Camila Esguerra)

3.    Biobanks, health registries and biomarker discovery (4 h)
a.    Use of population biobanks to understand human disease (1h, Kristian Hveem)
b.    Predictive medicine: Use of health registries and epidemiology (1h, Trude E. Robsahm)
c.    Cancer biomarkers (1h, Laxmi Silwal-Pandit)
d.    Biomarkers for early diagnosis and management of heart diseases (1h, Torbjørn Omland)

4.    Imaging disease (4 h) 
a.    Introduction to imaging modalities (1h, Lars Tore Gyland Mikalsen)
b.    Imaging cardiovascular diseases in animal models and patients (2h, Bill Louch/Magnus Arnonsen)
c.    Brain MR imaging in schizophrenia and bipolar disorder (1h, Ole Andreassen)

5.    Structure-based drug discovery (4.5 h)
a.    Basics of Chemical Biology and High throughput screening (0.5h, Johannes Landskron)
b.    Introduction to structural biology (1h, Hartmut Luecke)
c.    Introduction to cryoEM in drug design (1h, Eva Cunha)
d.    Drug development in the pharmaceutical industry (1h, Herbert Nar, BI)
e.    Molecular dynamics studies (1h, Matteo Dal Peraro, EPFL)

6.    Tailored and personalized medicine (7 h)
a.    Precision medicine in everyday practice - rare diseases (1h, Dag Undlien)
b.    Precision cancer medicine, implementation and the IMPRESS-Norway trial (1h, Kjetil Taskén)
c.    Drug sensitivity testing and personalized medicine (2h, Krister Wennerberg/ Bjørn Tore Gjertsen) 
d.    Utilizing common genetic variation to predict disease predisposition (2h, Samuli Ripatti, Elisabeth Widen)
e.    Nano-medicine (1h, Irep Gözen)

7.    Advanced cell-based therapies (4 h)
a.    Stem cells and their niche as a basis for future therapies (1h, Lorena Arranz)
b.    Cell based therapies in medicine – Laboratory work flow and clinical practice in cancer treatment (1h, Else Marit Inderberg)
c.    T cell receptor engineering and T cell therapies in cancer (1h, Johanna Olweus)
d.    Stem cell treatment in diabetes (1h, Hanne Scholz)

8.    Computational biology (6 h)
a.    Biostatistics and epidemiology (1h, Arnoldo Frigessi)
b.    Single cell genomics (1h, Oliver Stegle)
c.    Novel analytics in personalized medicine (2 h, Anthony Mathelier/Marieke Kuijjer)
d.    Deep learning in biomedicine (1h, Esa Pitkänen)
e.    Germline vs somatic mutations: commonalties, distinctions and interplay (1h, Sebastian Waszak)

9.    SARS-CoV-2 detection, vaccination and drug targeting (2.5 h)
a.    SARS-CoV-2 – a study of replication and immunity (1h, Christine Hanssen Rinaldo, UiT)
b.    Vaccine strategies (1h, Gunnveig Grødeland, KG Jebsen Center)
c.    Inhibitor development for Mpro, the main protease of SARS-CoV-2 (0.5h, Joel Heim)

10.    Organizational
a.    Introduction and organization (30 min, Elisa Bjørgo)


Published Aug. 20, 2020 1:10 PM - Last modified Oct. 23, 2020 11:47 AM